U.S. opioid use disorder market size from 2015 to 2026, by drug
In 2018, the total size of the opioid use disorder market in the U.S. for the drugs naltrexone, methadone, and buprenorphine was over 1.6 billion U.S. dollars. Buprenorphine accounted for 939 million dollars of this total. The opioid use disorder market size for buprenorphine is expected to grow to some 1.7 billion dollars by the year 2026.